Neuropediatrics 2023; 54(06): 407-411
DOI: 10.1055/s-0043-1771033
Short Communication

Evidence for a Pathogenic Role of CSMD1 in Childhood Apraxia of Speech

Daniela Formicola*
1   Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy
,
Irina Podda
2   Parole al Centro Studio di Logopedia, Genoa, Italy
,
Marilena Pantaleo
3   Medical Genetics Unit, Meyer Children's University Hospital, Florence, Italy
,
3   Medical Genetics Unit, Meyer Children's University Hospital, Florence, Italy
,
Diego Lopergolo
1   Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy
,
Sabrina Giglio
4   Department of Medical Sciences and Public Health, Medical Genetics Unit, University of Cagliari, Cagliari, Italy
,
Filippo Maria Santorelli
1   Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy
5   Department of Developmental Neuroscience, IRCCS “Stella Maris Foundation” Scientific Institute, Pisa, Italy
,
Anna Chilosi
5   Department of Developmental Neuroscience, IRCCS “Stella Maris Foundation” Scientific Institute, Pisa, Italy
› Author Affiliations
Funding This work was supported in part by funding from the Italian Ministry of Health (RF2016-02361560 to A.C.; RC 5 × 1000 to FMS and AC).

Abstract

Childhood apraxia of speech (CAS) is a pediatric motor speech disorder. The genetic etiology of this complex neurological condition is not yet well understood, although some genes have been linked to it. We describe the case of a boy with a severe and persistent motor speech disorder, consistent with CAS, and a coexisting language impairment.

Whole exome sequencing in our case revealed a de novo and splicing mutation in the CSMD1 gene.

Author Contributions

A.C., F.M.S., D.F. and I.P. drafted the manuscript. D.F. performed wet-lab (sample processing steps) and W.E.S. data analysis. M.P. performed array-CGH. A.C. and I.P. collected and analyzed clinical data. D.L. performed genetic counseling. A.C., F.M.S., D.F., S.G. and E.A. critically reviewed the manuscript. A.C. and D.F. designed the study. F.M.S. reviewed the study design. All authors have read and approved the final version of the manuscript.


* Present address: UOC Medical Genetics, S. Camillo Hospital, Rome, Italy.




Publication History

Received: 07 November 2022

Accepted: 14 June 2023

Article published online:
07 August 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 ASHA. American Speech-Language-Hearing Association - ASHA, Childhood apraxia of speech [Technical Report]. 2007 ; Retrieved from https://www.asha.org/practice-portal/clinical-topics/childhood-apraxia-of-speech/
  • 2 Shriberg LD, Potter NL, Strand EA. Prevalence and phenotype of childhood apraxia of speech in youth with galactosemia. J Speech Lang Hear Res 2011; 54 (02) 487-519
  • 3 Chilosi AM, Podda I, Ricca I. et al. Differences and commonalities in children with childhood apraxia of speech and comorbid neurodevelopmental disorders: a multidimensional perspective. J Pers Med 2022; 12 (02) 313
  • 4 Provenzano A, La Barbera A, Scagnet M. et al. Chiari 1 malformation and exome sequencing in 51 trios: the emerging role of rare missense variants in chromatin-remodeling genes. Hum Genet 2021; 140 (04) 625-647
  • 5 Hayden DA, Square P. Verbal Motor Production Assessment for Children (VMPAC). San Antonio, TX: The Psychological Corporation; 1999
  • 6 Chilosi AM. Cipriani. TCGB, Test di Comprensione Grammaticale per Bambini: D. Cerro Ed. Pisa; 2005
  • 7 Chilosi AM, Pfanner L, Pecini C. et al. Which linguistic measures distinguish transient from persistent language problems in Late Talkers from 2 to 4 years? A study on Italian speaking children. Res Dev Disabil 2019; 89: 59-68
  • 8 Cipriani P, Chilosi AM, Bottari P, Pfanner L. L'acquisizione della morfosintassi in italiano: fasi e processi. Padua: Unipress; 1993
  • 9 Sanders SJ, Murtha MT, Gupta AR. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012; 485 (7397) 237-241
  • 10 Guo H, Wang T, Wu H. et al. Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model. Mol Autism 2018; 9: 64
  • 11 Kraus DM, Elliott GS, Chute H. et al. CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J Immunol 2006; 176 (07) 4419-4430
  • 12 Steen VM, Nepal C, Ersland KM. et al. Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. PLoS One 2013; 8 (11) e79501
  • 13 Koiliari E, Roussos P, Pasparakis E. et al. The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males. Schizophr Res 2014; 154 (1-3): 42-47
  • 14 Athanasiu L, Giddaluru S, Fernandes C. et al. A genetic association study of CSMD1 and CSMD2 with cognitive function. Brain Behav Immun 2017; 61: 209-216
  • 15 Ermis Akyuz E, Bell SM. The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases. Genes (Basel) 2022; 13 (12) 2332
  • 16 Bickart K, Napolioni V. et al. Genetic variation in CSMD1 affects amygdala connectivity and prosocial behavior. bioRxiv 2020
  • 17 Glancy M, Barnicoat A, Vijeratnam R. et al. Transmitted duplication of 8p23.1-8p23.2 associated with speech delay, autism and learning difficulties. Eur J Hum Genet 2009; 17 (01) 37-43